Good point.Again using CD3's values at 31/3/22, KNBE is also held by US SelectDirect PE II with A$37.2m = 26.9% of CD3’s LP investments. So pro-rata to my first analysis, the total net proceeds might be (12.1+ 26.9)/12.1= 3.223 x about A$2.0m after tax. say A$6.5m cash to CD3.
As you say, holdings in each subfund may be bigger than my 10-15% guess. In general , one would expect the 30 Sept NAV of CD3 to be based on the subfunds’ values at 30 June for their unlisted assets (ie typical 3 month lag) , but I don’t know if they would update the values of listed holdings to the 30/9 market values.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.000(0.00%) |
Mkt cap ! $84.99M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.19 | $1.18 | $66.37K | 56.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11360 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 500 | 1 |
View Market Depth
| Last trade - 10.31am 25/06/2025 (20 minute delay) ? |
| CD3 (ASX) Chart |